|Commercial Alert hopes to mobilize public opinion against the dangers of prescription drug advertising.
200 MED SCHOOL PROFESSORS CONDEMN DTC ADVERTISING
Commercial Alert Organizes Effort to Back Upcoming FDA Testiomny
COMMERCIAL ALERT SEEKS FTC BUZZ MARKETING INVESTIGATION
Singles Out P&G's Tremor for 'Targeting of Minors'
CELLPHONE MARKETING TO CHILDREN ATTACKED
Commercial Alert Wants Congress to Enact New Regulations
FTC REJECTS COMMERCIAL ALERT PRODUCT PLACEMENT PETITION
Finds Existing Disclosure Rules Adequate
MUCH OF WHAT ADVERTISERS ARE DOING IS AN INVASION OF PRIVACY
Why Public Sentiment Is Rising Against Relentlessly Intrusive Marketing
FTC/FCC COMPLAINT CHALLENGES PRODUCT PLACEMENT
Action By Ralph Nader Group Calls for TV Content Labeling
Commercial Alert's director, Gary Ruskin, said the purpose of the Web site is to educate the public about the dangers of prescription drug advertising, and to mobilize thousands of Americans to voice their opposition to the ads.
Mr. Ruskin is leading the charge as the Food and Drug Administration continues to accept public comment on DTC prescription drug advertising until Feb. 28. The Web site states that it is not the role of drug executives to tell Americans which drugs to buy, and it encourages visitors to send comments to the FDA in opposition to DTC advertising.
'Should be illegal'
“In effect, drug companies are practicing medicine without a license, and that should be illegal,” Mr. Ruskin said. “We’ve got to halt prescription drug advertising before the next Vioxx tragedy happens.”
The FDA held two days of public hearings in November to take public comments both for and against DTC advertising, as the agency hopes to render a new policy regarding the $4 billion industry later this year.
Days before the hearings, Commercial Alert released a statement from 211 professors from U.S. medical schools that “direct-to-consumer marketing of prescription drugs should be prohibited.”
Prominent medical school professors
The statement’s endorsers include prominent medical school professors from Harvard, Johns Hopkins, University of Pennsylvania, Columbia, Stanford, Yale, Duke, University of California-San Francisco and other top medical schools, along with two former editors in chief of the New England Journal of Medicine.